Murphy & Mullick Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Murphy & Mullick Capital Management's ARKG Position: Q3 2026 in Review
Murphy & Mullick Capital Management held its ARK Genomic Revolution ETF (ARKG) position steady in Q3 2026 at 20 shares worth $1.08K. The position accounts for ﹤0.01% of the portfolio, ranked #657.
Murphy & Mullick Capital Management first reported a position in ARKG in Q4 2024 and has held it in 8 quarters since. 316 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.
- Murphy & Mullick Capital Management held 20 shares of ARK Genomic Revolution ETF worth $1.08K as of Q3 2026.
- Murphy & Mullick Capital Management left its ARK Genomic Revolution ETF share count unchanged in Q3 2026.
- ARK Genomic Revolution ETF made up ﹤0.01% of Murphy & Mullick Capital Management's portfolio in Q3 2026, its #657 holding.
- Murphy & Mullick Capital Management first reported a position in ARK Genomic Revolution ETF in Q4 2024 and has held it in 8 quarters since.
- 316 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.
Based on Murphy & Mullick Capital Management's 13F filing for Q3 2026, filed 2 Nov 2026.